Advances in plant molecular farming
OO Obembe, JO Popoola, S Leelavathi… - Biotechnology advances, 2011 - Elsevier
Plant molecular farming (PMF) is a new branch of plant biotechnology, where plants are
engineered to produce recombinant pharmaceutical and industrial proteins in large …
engineered to produce recombinant pharmaceutical and industrial proteins in large …
Plants as bioreactors: recent developments and emerging opportunities
In recent years, the use of plants as bioreactors has emerged as an exciting area of research
and significant advances have created new opportunities. The driving forces behind the …
and significant advances have created new opportunities. The driving forces behind the …
Genetic diversity in tomato (Solanum lycopersicum) and its wild relatives
Tomato, ranking 1st in the world for vegetables, accounts for 14% of world vegetable
production (over 100 million metric tons/year $1.6 billion market;(Food and Agriculture …
production (over 100 million metric tons/year $1.6 billion market;(Food and Agriculture …
Plants as bioreactors for the production of vaccine antigens
Plants have been identified as promising expression systems for commercial production of
vaccine antigens. In phase I clinical trials several plant-derived vaccine antigens have been …
vaccine antigens. In phase I clinical trials several plant-derived vaccine antigens have been …
Improving protein quantity and quality—The next level of plant molecular farming
Plants offer several unique advantages in the production of recombinant pharmaceuticals for
humans and animals. Although numerous recombinant proteins have been expressed in …
humans and animals. Although numerous recombinant proteins have been expressed in …
Recombinant plant-derived pharmaceutical proteins: current technical and economic bottlenecks
M Sabalza, P Christou, T Capell - Biotechnology letters, 2014 - Springer
Molecular pharming is a cost-effective platform for the production of recombinant proteins in
plants. Although the biopharmaceutical industry still relies on a small number of …
plants. Although the biopharmaceutical industry still relies on a small number of …
Effects of intestinal microbiota on physiological metabolism and pathogenicity of Vibrio
H Sun, C Zhu, X Fu, S Khattak, J Wang, Z Liu… - Frontiers in …, 2022 - frontiersin.org
Vibrio species are disseminated broadly in the marine environment. Some of them can
cause severe gastroenteritis by contaminating seafood and drinking water, such as Vibrio …
cause severe gastroenteritis by contaminating seafood and drinking water, such as Vibrio …
The use of plants for the production of therapeutic human peptides
C Lico, L Santi, RM Twyman, M Pezzotti, L Avesani - Plant cell reports, 2012 - Springer
Peptides have unique properties that make them useful drug candidates for diverse
indications, including allergy, infectious disease and cancer. Some peptides are intrinsically …
indications, including allergy, infectious disease and cancer. Some peptides are intrinsically …
Recent advances and safety issues of transgenic plant-derived vaccines
Z Guan, B Guo, Y Huo, Z Guan, J Dai, Y Wei - Applied microbiology and …, 2013 - Springer
Transgenic plant-derived vaccines comprise a new type of bioreactor that combines plant
genetic engineering technology with an organism's immunological response. This …
genetic engineering technology with an organism's immunological response. This …
Optimizing the yield of recombinant pharmaceutical proteins in plants
RM Twyman, S Schillberg… - Current Pharmaceutical …, 2013 - ingentaconnect.com
The production of recombinant pharmaceutical proteins in plants is entering a new phase
with the recent approval of recombinant glucocerebrosidase produced in carrot cells and the …
with the recent approval of recombinant glucocerebrosidase produced in carrot cells and the …